1News 1News — your global news briefing, coming soon on iOS & Android
Coming Soon
1News 1News
Top Business Entertainment Sports Technology Politics Science Lifestyle
Back to Business
UCB to acquire Candid Therapeutics for up to $2.2 billion
Business May 3, 2026 at 5:18 PM

UCB to acquire Candid Therapeutics for up to $2.2 billion

Investing.com
Read at Investing.com
More Stories
Netflix’s ‘Adolescence’ Follow-Up Show Has A 92% Rotten Tomatoes Score
Business
Netflix’s ‘Adolescence’ Follow-Up Show Has A 92% Rotten Tomatoes Score

Netflix's best new show has a near-perfect Rotten Tomatoes score, and it just so happens to be a follow-up to Adolescenc…

🇺🇸 Forbes Business 35m ago
German chancellor downplays row with Trump after troop drawdown announced
Business
German chancellor downplays row with Trump after troop drawdown announced
🇺🇸 Investing.com 45m ago
LG Display Q1 2026 slides: OLED shift advances amid revenue decline
Business
LG Display Q1 2026 slides: OLED shift advances amid revenue decline
🇺🇸 Investing.com 50m ago
1News
Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play
1News 1News

Your global news briefing — 300+ sources, 12 countries, 10 languages.

Support 1News Settings Search AI Info

© 2026 1News. The world's news, curated for you.